INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 66 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $26,000 | -25.7% | 25,000 | 0.0% | 0.01% | -31.2% |
| Q2 2019 | $35,000 | -18.6% | 25,000 | 0.0% | 0.02% | -20.0% |
| Q1 2019 | $43,000 | -46.9% | 25,000 | -16.7% | 0.02% | -47.4% |
| Q4 2018 | $81,000 | 0.0% | 30,000 | 0.0% | 0.04% | +2.7% |
| Q3 2018 | $81,000 | +42.1% | 30,000 | 0.0% | 0.04% | +32.1% |
| Q2 2018 | $57,000 | +35.7% | 30,000 | +50.0% | 0.03% | +27.3% |
| Q1 2018 | $42,000 | – | 20,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
| EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
| Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
| Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
| MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
| Bleichroeder LP | 250,000 | $298,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
| Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |